Markers of coagulation disruption in COVID-19 currently under investigation include D-dimer levels, platelet count, Von Willebrand Factor (VWF), Factor VIII, thromboelastography (TEG), lupus anticoagulant (LAC), antiphospholipid antibodies (APLs), and fibrinogen. Here, VWF is linked to COVID-19.